Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

COVID-19 Vaccination for Immunosuppressed Patients: From Guidance to Advocacy

Joseph Cantrell, JD  |  March 18, 2021

This effort involved multiple ACR departments and committees and built on a long history of working with internal and external partners, including state and local rheumatology societies. The connections between different ACR priorities, such as clinical guidance and advocacy, may not always be immediately clear. But the effort to improve COVID-19 vaccination of rheumatology patients, from the development of clinical guidance though state outreach to get those patients access to vaccines, has been a shining example of the great strength of ACR advocacy.

One of the most effective parts of rheumatology’s advocacy capacity comes from the ability to translate the work of the ACR into strong, actionable public policy recommendations, then amplify those messages through member engagement. ACR/ARP members sent over 500 messages to state leaders supporting the ACR’s position on vaccinations. Additionally, our volunteer leaders and staff put in countless hours, often on evenings and weekends, to execute every phase of this strategy, from the formulation of the clinical guidance to the final media outreach. It took many different parts of the ACR working together to achieve this win for the patients that our members treat. It is, however, an important reminder of how strong and effective this organization and the rheumatology community can be when working toward a common goal. After more than a year of living in this pandemic, patients are one step closer to resuming a normal life because of the work of the ACR and its members. That is truly an accomplishment to celebrate.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Joseph Cantrell, JD, is the senior manager of state affairs for the ACR.

Page: 1 2 | Single Page
Share: 

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:ACR advocacyCOVID-19state societyvaccination

Related Articles

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    The ACR’s Congressional Advocacy Produces Results

    June 21, 2018

    The underlying tenet of the ACR’s advocacy efforts is that we cannot effect change for our profession and our patients unless we take our issues directly to decision makers. As I write this column, I am highly encouraged by the progress we have made so far this year in the advocacy realm. At the same…

    A Unified Advocacy Voice for Rheumatology

    June 13, 2021

    One thing that became clear very quickly this past year was that the COVID-19 pandemic would change the way we deliver care to patients. What has not changed amid an evolving healthcare landscape is our driving focus to ensure our patients’ access to rheumatology care and the availability of state-of-the-art treatments. We know you share…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences